Air Products and Chemicals, Inc. APD SPX

Basic Materials · Specialty Chemicals · United States

https://www.airproducts.com

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and related services in the Americas, Asia, Europe, the Middle East, India, and internationally. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, and syngas; and specialty gases for customers in various industries, including refining, chemical, metals, manufacturing, electronics, energy production, medical, food, chemical and petrochemical manufacturing, oil and gas recovery and processing, and steel and primary metals processing. It also designs and manufactures equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and liquid helium and liquid hydrogen transport and storage. Air Products and Chemicals, Inc. was founded in 1940 and is headquartered in Allentown, Pennsylvania.

Market & Price

Market Cap

$62.04B

Current Price

$278.62

High / Low (52W)

$306.20 / $227.66

Beta

0.78

Valuation

Stock P/E

29.33

Industry PE

24.80

Forward P/E

19.57

PEG Ratio

2.31

Book Value

$70.28

Price to Book

3.96

P/S

4.98

EV/EBITDA

21.16

Dividend Yield

2.60%

Profitability & Returns

ROCE

-0.62%

ROE

12.35%

ROA

3.60%

Profit Margin

16.91%

Op Margin

23.59%

EPS (Latest Qtr)

$3.19

EPS (TTM)

$9.50

Balance Sheet & Liquidity

Debt/Equity

1.02

Quick Ratio

0.98

Current Ratio

1.43

Debt

$18.44B

Total Assets

$41.06B

Current Assets

$5.83B

Working Capital

$1.61B

Ownership

Promoter Holding

1.88%

Chg in Prom Hold

-0.00%

FII / Inst Holding

92.98%

Chg in FII Hold

0.01%

Financial Snapshot

Enterprise Value

$82.03B

Total Revenue (TTM)

$12.46B

EBITDA

$3.88B

Free Cash Flow

$-3.52B

Operating Cash Flow

$4.12B

Shares Outstanding

222.68M

Gross Margin

31.98%

Payout Ratio

75.66%

Growth (CAGR)

Revenue 5Y

-1.77%

Profit 5Y

-39.16%

Revenue (YoY)

8.80%

Earnings (YoY)

PROS

Attractive dividend yield of 2.60%.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Revenue declined at -1.8% CAGR over 5 years.
Earnings shrank at -39.2% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Basic Materials).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	APD Air Products and Chemicals, Inc. SPX	278.62	29.33	$62.04B	2.60%	-0.62%	12.35%	-1.77%	-39.16%
2	LIN Linde plc NDXSPX	497.69	33.00	$230.11B	1.29%	13.07%	18.23%	0.62%	18.48%
3	NEM Newmont Corporation SPX	109.81	14.24	$117.23B	0.95%	22.51%	25.83%	23.91%	583.84%
4	FCX Freeport-McMoRan Inc. SPX	65.71	34.77	$94.46B	0.91%	12.93%	15.63%	4.39%	-14.02%
5	SHW The Sherwin-Williams Company SPX	303.84	29.16	$74.94B	1.05%	20.04%	60.72%	2.10%	8.34%
6	CRH CRH plc SPX	108.79	20.18	$72.69B	1.43%	11.33%	15.81%	4.60%	-1.15%
7	ECL Ecolab Inc. SPX	256.00	34.59	$72.05B	1.14%	14.89%	22.43%	4.26%	23.88%
8	NUE Nucor Corporation SPX	250.00	24.80	$56.94B	0.90%	8.80%	12.29%	-7.84%	-38.80%
9	CTVA Corteva, Inc. SPX	78.28	42.31	$52.36B	0.92%	6.08%	5.14%	-0.10%	-1.56%

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Dec 2021	Mar 2022	Jun 2022	Dec 2022	Mar 2023	Jun 2023	Dec 2023	Mar 2024	Jun 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	1.88B	1.98B	2.12B	2.20B	2.22B	2.16B	2.26B	2.30B	2.22B	2.19B	2.22B	2.28B	2.25B	2.22B	2.07B	2.32B	2.38B	2.50B	2.60B	2.99B	2.95B	3.19B	3.17B	3.20B	3.03B	3.00B	2.93B	2.99B	-	2.92B	3.02B	3.17B	3.10B	3.17B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.05B	2.04B	2.15B	2.11B	2.18B
Gross Profit	755.00M	753.50M	570.40M	564.40M	594.30M	598.00M	565.80M	576.30M	635.90M	658.10M	644.80M	649.20M	713.60M	733.10M	651.00M	713.00M	758.00M	792.40M	768.10M	756.20M	720.30M	753.60M	-	-	-	-	-	-	-	-	-	-	-	-	-	862.30M	982.60M	1.02B	995.00M	987.40M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	231.00M	210.20M	209.60M	238.50M	234.70M
Operating Income	424.80M	474.30M	372.50M	371.60M	394.60M	391.00M	328.30M	395.60M	258.70M	457.40M	460.70M	455.40M	515.80M	533.70M	455.00M	516.50M	569.70M	603.20M	561.00M	577.20M	539.20M	560.20M	539.10M	548.50M	577.10M	523.00M	561.90M	627.40M	652.00M	459.80M	644.20M	666.90M	637.20M	737.60M	-	631.30M	772.40M	811.80M	756.50M	752.70M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.82B	1.35B	601.90M	1.28B	1.31B
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	42.20M	61.40M	67.80M	54.50M	49.50M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2.24B	890.80M	121.30M	850.80M	883.50M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-505.80M	159.60M	111.20M	159.40M	158.70M
Net Income	318.80M	344.50M	363.60M	-473.30M	346.80M	394.00M	299.80M	2.13B	101.90M	468.70M	154.60M	416.40M	473.90M	452.90M	347.50M	421.30M	488.00M	503.20M	475.60M	477.80M	446.50M	486.80M	482.00M	473.10M	533.60M	560.40M	530.50M	582.10M	572.20M	439.80M	595.60M	609.30M	572.40M	696.60M	-	-1.73B	713.80M	4.90M	678.20M	710.40M
Diluted EPS	1.47	1.58	1.67	-2.17	1.59	1.80	1.37	9.70	0.46	2.13	0.70	1.89	2.15	2.05	1.57	1.90	2.20	2.27	2.14	2.15	2.01	2.19	2.17	2.13	2.40	2.52	2.38	2.62	2.57	1.97	2.67	2.73	2.57	3.13	-	-7.77	3.20	0.02	3.04	3.19
R&D Expense	33.40M	-	16.90M	18.20M	18.70M	-	15.00M	14.80M	14.60M	-	14.60M	14.50M	15.00M	-	15.00M	16.90M	18.10M	-	17.70M	19.20M	19.90M	-	23.50M	21.10M	23.20M	23.30M	23.70M	24.80M	24.40M	27.20M	29.30M	25.70M	25.40M	27.00M	22.00M	22.90M	24.10M	-	20.40M	21.60M

Profit & Loss (Annual)

Figures in USD.

Metric	Sep 2007	Sep 2008	Sep 2009	Sep 2010	Sep 2011	Sep 2012	Sep 2013	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Revenue	-	-	-	-	-	-	-	-	-	7.50B	8.19B	8.93B	8.92B	8.86B	-	12.70B	12.60B	12.10B	12.04B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9.34B	8.83B	8.17B	8.26B
Gross Profit	-	-	2.21B	2.52B	2.58B	2.56B	2.71B	2.80B	2.96B	2.33B	2.44B	2.74B	2.91B	3.00B	-	3.36B	3.77B	3.93B	3.78B
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	947.60M	1.03B	984.40M	892.30M
Operating Income	1.38B	1.50B	846.30M	1.27B	1.51B	1.28B	1.32B	1.34B	1.23B	1.54B	1.44B	1.97B	2.14B	2.24B	-	2.41B	2.74B	2.95B	2.89B
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.22B	4.42B	6.49B	1.34B
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	128.00M	177.50M	218.80M	214.00M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.75B	2.88B	4.82B	-440.70M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	500.80M	551.20M	944.90M	-94.30M
Net Income	1.04B	909.70M	631.30M	1.03B	1.22B	1.17B	994.20M	991.70M	1.28B	631.10M	3.00B	1.50B	1.76B	1.89B	-	2.26B	2.30B	3.83B	-394.50M
Diluted EPS	4.64	4.15	2.96	4.74	5.63	5.44	4.68	4.61	5.88	2.89	13.65	6.78	7.94	8.49	-	10.14	10.33	17.18	-1.77
R&D Expense	129.00M	130.70M	116.30M	114.70M	118.80M	126.40M	133.70M	139.80M	76.40M	71.80M	57.60M	64.50M	72.90M	83.90M	93.50M	102.90M	105.60M	100.20M	96.30M

Compounded Sales Growth

5 Years:	-1.77%
1 Year:	8.80%

Compounded Profit Growth

5 Years:	-39.16%
1 Year:	-

Stock Price Performance

1 Year:	+2.58%
6 Months:	+9.07%
3 Months:	+1.70%
1 Month:	-7.89%

Balance Sheet (Annual)

Figures in USD.

Metric	Sep 2006	Sep 2007	Sep 2008	Sep 2009	Sep 2010	Sep 2011	Sep 2012	Sep 2013	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Oct 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Assets	-	-	12.57B	13.03B	13.51B	14.29B	16.94B	17.85B	17.67B	17.32B	18.03B	18.47B	19.18B	19.20B	18.94B	25.17B	-	27.19B	32.00B	39.57B	41.06B
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.28B	5.20B	6.36B	5.83B
Cash & Equivalents	31.00M	40.50M	103.50M	488.20M	373.70M	421.40M	454.40M	450.40M	336.60M	183.10M	1.29B	3.27B	2.79B	2.79B	2.25B	5.25B	-	2.71B	1.62B	2.98B	1.86B
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	514.20M	651.80M	766.00M	776.50M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.79B	1.70B	1.82B	1.90B
Total Liabilities	-	-	7.40B	8.10B	7.81B	8.35B	9.93B	10.28B	9.97B	9.95B	10.82B	8.28B	8.00B	8.03B	7.55B	12.73B	-	13.49B	16.34B	20.90B	23.71B
Current Liabilities	-	-	2.21B	2.50B	2.24B	2.34B	2.69B	3.23B	2.96B	3.64B	3.28B	2.49B	2.34B	2.36B	1.82B	2.42B	-	3.47B	3.90B	4.18B	4.22B
Long Term Debt	-	-	3.52B	3.72B	3.66B	3.93B	4.58B	5.06B	4.82B	3.95B	4.92B	-	-	-	-	-	-	7.09B	9.43B	13.53B	16.95B
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.33B	11.03B	15.01B	18.41B
Total Equity	4.92B	5.50B	5.03B	4.79B	5.55B	5.80B	6.48B	7.04B	7.37B	7.25B	7.08B	10.09B	10.86B	-	11.05B	12.08B	-	13.14B	14.31B	17.04B	15.02B
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	249.46M	249.46M	249.46M	249.46M

Cash Flows (Annual)

Figures in USD.

Metric	Sep 2007	Sep 2008	Sep 2009	Sep 2010	Sep 2011	Sep 2012	Sep 2013	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Operating Cash Flow	1.50B	1.66B	1.33B	1.52B	1.75B	-	-	-	-	-	-	-	-	-	-	3.23B	3.21B	3.65B	3.26B
Investing Cash Flow	-1.48B	-919.80M	-1.04B	-1.06B	-1.21B	-	-	-	-	-	-	-	-	-	-	-3.86B	-5.92B	-4.92B	-7.17B
Financing Cash Flow	-14.90M	-677.70M	95.00M	-579.70M	-484.50M	-	-	-	-	-	-	-	-	-	-	-1.00B	1.61B	2.62B	2.80B
Capital Expenditure	-1.01B	-1.09B	-1.18B	-988.70M	-1.31B	-1.52B	-1.52B	-1.36B	-1.16B	-907.70M	-1.04B	-1.57B	-1.99B	-2.51B	-	-2.93B	-4.63B	-6.80B	-7.02B
Free Cash Flow	486.70M	573.70M	150.30M	533.70M	443.90M	-	-	-	-	-	-	-	-	-	-	303.70M	-1.42B	-3.15B	-3.77B
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.63B	-1.10B	1.34B	-1.12B
Share Buybacks	575.20M	793.40M	0	0	649.20M	53.10M	461.60M	0	0	-	-	-	-	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Sep 2007	Sep 2008	Sep 2009	Sep 2010	Sep 2011	Sep 2012	Sep 2013	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	31.0%	29.8%	30.7%	32.7%	33.9%	-	26.5%	29.9%	32.5%	31.4%
Operating Margin %	-	-	-	-	-	-	-	-	-	20.5%	17.6%	22.0%	24.0%	25.3%	-	19.0%	21.7%	24.4%	24.0%
Net Margin %	-	-	-	-	-	-	-	-	-	8.4%	36.6%	16.8%	19.7%	21.3%	-	17.8%	18.3%	31.6%	-3.3%
ROE %	18.8%	18.1%	13.2%	18.6%	21.1%	18.0%	14.1%	13.5%	17.6%	8.9%	29.7%	13.8%	15.9%	15.6%	-	17.2%	16.1%	22.5%	-2.6%
ROCE %	-	14.4%	8.0%	11.3%	12.6%	9.0%	9.1%	9.1%	9.0%	10.4%	9.0%	11.7%	12.5%	9.8%	-	10.2%	9.7%	8.3%	7.8%

Shareholding Pattern

Insiders

1.88%

Institutions

92.98%

Public Float

94.76%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	8.11%	18.05M	$5.03B
2	Vanguard Capital Management LLC	6.50%	14.47M	$4.03B
3	State Farm Mutual Automobile Insurance Co	5.32%	11.84M	$3.30B
4	Capital Research Global Investors	4.68%	10.41M	$2.90B
5	State Street Corporation	4.54%	10.11M	$2.82B
6	Capital International Investors	4.46%	9.94M	$2.77B
7	Dodge & Cox Inc.	4.15%	9.23M	$2.57B
8	JPMORGAN CHASE & CO	2.72%	6.05M	$1.69B
9	Vanguard Portfolio Management LLC	2.56%	5.71M	$1.59B
10	Geode Capital Management, LLC	2.24%	4.99M	$1.39B

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for APD

No recent headlines available.

APD · Basic Materials